Huaping Zhang

Title: Huaping Zhang: Innovator in Pharmaceutical Research

Introduction

Huaping Zhang is a notable inventor based in Newark, DE (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of selective inhibitors for protein arginine methyltransferase 5 (PRMT5). His work has implications for various therapeutic applications.

Latest Patents

Huaping Zhang holds a patent for selective inhibitors of protein arginine methyltransferase 5 (PRMT5). The patent disclosure is directed to pharmaceutically acceptable salts of the compound of Formula I. Additionally, it describes pharmaceutical compositions comprising these salts, as well as methods for their use and preparation. He has 1 patent to his name.

Career Highlights

Zhang is currently associated with Prelude Therapeutics Incorporated, where he continues to advance his research in the pharmaceutical sector. His work is pivotal in the development of new therapeutic agents that target specific biological pathways.

Collaborations

He has collaborated with notable colleagues such as Ganfeng Cao and Hongwu Yu, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Huaping Zhang's contributions to pharmaceutical research and his innovative patent work highlight his role as a key figure in the field. His ongoing efforts at Prelude Therapeutics Incorporated continue to pave the way for advancements in medical treatments.